BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21487569)

  • 1. Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China.
    Zhang H; He SM; Sun J; Wang C; Jiang YF; Gu Q; Feng XW; Du B; Wang W; Shi XD; Zhang SQ; Li WY; Niu JQ
    Int J Med Sci; 2011 Mar; 8(3):254-62. PubMed ID: 21487569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology and prevalence of abnormal serum alanine aminotransferase levels in a general population in Northeast China.
    Zhang H; Jiang YF; He SM; Sun J; Gu Q; Feng XW; DU B; Wang W; Shi XD; Wang CY; Zhang SQ; Li WY; Niu JQ
    Chin Med J (Engl); 2011 Sep; 124(17):2661-8. PubMed ID: 22040420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample.
    Flechtner-Mors M; George SN; Oeztuerk S; Haenle MM; Koenig W; Imhof A; Boehm BO; Graeter T; Mason RA; Kratzer W; Akinli AS;
    BMC Res Notes; 2014 Apr; 7():207. PubMed ID: 24693952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town.
    Pendino GM; Mariano A; Surace P; Caserta CA; Fiorillo MT; Amante A; Bruno S; Mangano C; Polito I; Amato F; Cotichini R; Stroffolini T; Mele A;
    Hepatology; 2005 May; 41(5):1151-9. PubMed ID: 15841464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.
    Eguchi Y; Hyogo H; Ono M; Mizuta T; Ono N; Fujimoto K; Chayama K; Saibara T;
    J Gastroenterol; 2012 May; 47(5):586-95. PubMed ID: 22328022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.
    Hsieh MH; Ho CK; Hou NJ; Hsieh MY; Lin WY; Yang JF; Chiu CC; Huang JF; Chang NC; Wang CL; Dai CY; Chuang WL; Yu ML
    Int J Obes (Lond); 2009 Nov; 33(11):1309-17. PubMed ID: 19752878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
    Whitfield JB; Zhu G; Madden PAF; Montgomery GW; Heath AC; Martin NG
    Alcohol Clin Exp Res; 2019 Mar; 43(3):473-482. PubMed ID: 30589442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia.
    Loke SS; Yang KD; Chen KD; Chen JF
    World J Gastroenterol; 2013 Sep; 19(35):5883-8. PubMed ID: 24124334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.
    Lee SW; Lee TY; Yang SS; Peng YC; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):176-180. PubMed ID: 28381382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal transaminase and lipid profiles in coexisting diseases in patients with fatty liver: a population study in Sichuan.
    Jiang W; Liu CH; Wu D; Wang YJ; Tang H
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34918746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.
    Lobstein S; Kaiser T; Liebert U; Wojan M; Leichtle A; Mössner J; Wiegand J; Tillmann HL
    Z Gastroenterol; 2008 May; 46(5):415-20. PubMed ID: 18461515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China.
    Zheng JS; Xu A; Huang T; Yu X; Li D
    Lipids; 2012 Jun; 47(6):549-56. PubMed ID: 22527845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
    Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S
    Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients.
    Giandalia A; Romeo EL; Ruffo MC; Muscianisi M; Giorgianni L; Forte F; Cucinotta D; Russo GT
    Prim Care Diabetes; 2017 Jun; 11(3):226-232. PubMed ID: 28017576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors associated with non-alcoholic fatty liver disease: a case-control study].
    Caballería L; Arteaga I; Pera G; Rodríguez L; Alumà A; Auladell MA; Torán P
    Med Clin (Barc); 2013 Sep; 141(6):233-9. PubMed ID: 23601740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
    Papatheodoridis GV; Goulis J; Christodoulou D; Manolakopoulos S; Raptopoulou M; Andrioti E; Alexandropoulos N; Savvidou S; Papachristou A; Zervou E; Seferiadis K; Kousidou P; Vogiatzakis E; Tsianos E
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):281-7. PubMed ID: 17353691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mildly Elevated Liver Transaminase Levels: Causes and Evaluation.
    Oh RC; Hustead TR; Ali SM; Pantsari MW
    Am Fam Physician; 2017 Dec; 96(11):709-715. PubMed ID: 29431403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.